Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc., 3197 [2021-00648]
Download as PDF
<![CDATA[
3197
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
khammond on DSKJM1Z7X2PROD with NOTICES
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Extension with change of a currently
approved collection.
2. The Title of the Form/Collection:
Records and Supporting Data:
Importation, Receipt, Storage, and
Disposition by Explosives Importers,
Manufacturers, Dealers, and Users
Licensed Under Title 18 U.S.C. Chapter
40 Explosives.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): None.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other (if applicable): None.
Abstract: This information collection
requires the maintenance of records
showing daily activities in the
importation, manufacture, receipt,
storage, and disposition of all explosive
materials covered under 18 U.S.C.
Chapter 40 Explosives. These records
must also show where and to whom
explosive materials are sent, thereby
ensuring that any diversions will be
readily apparent, and that ATF will be
immediately notified if these materials
are lost or stolen.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 9,411
respondents will prepare records for
this information collection annually,
and it will take each respondent
approximately 12.6 hours to prepare the
required records.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
592,893 hours, which is equal to 47,055
VerDate Sep<11>2014
03:30 Jan 14, 2021
Jkt 253001
(# of annual responses) * 12.6 (# of
hours per response).
7. An Explanation of the Change in
Estimates: The adjustments associated
with this collection include a decrease
in the number of respondents, responses
and total burden hours by 516, 2,580,
and 32,508 hours respectively, since the
last IC renewal in 2017.
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
following basic class of controlled
substance:
Controlled substance
Ecgonine .......................
Drug
code
9180
Schedule
II
The company plans to produce the
listed controlled substance in bulk to be
used in the manufacture of DEA exempt
products. No other activities for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–00648 Filed 1–13–21; 8:45 am]
Dated: January 11, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
BILLING CODE P
[FR Doc. 2021–00743 Filed 1–13–21; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–02–P
[Docket No. DEA–766]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Bulk Manufacturer of Controlled
Substances Application: Siemens
Healthcare Diagnostics Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Siemens Healthcare
Diagnostics Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 15, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 15, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 11, 2020,
Siemens Healthcare Diagnostics Inc.,
100 GBC Drive, Mailstop 514, Newark,
Delaware 19702–2461, applied to be
registered as a bulk manufacturer of the
SUPPLEMENTARY INFORMATION:
Frm 00089
Fmt 4703
Bulk Manufacturer of Controlled
Substances Application: IsoSciences,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
[Docket No. DEA–768]
PO 00000
DEPARTMENT OF JUSTICE
Sfmt 4703
IsoSciences, LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 15, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 15, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2020,
IsoSciences, LLC, 340 Mathers Road,
Ambler, Pennsylvania 19002–3420,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
Cathinone ................................
Methcathinone ........................
Lysergic acid diethylamide .....
Marihuana ...............................
E:\FR\FM\14JAN1.SGM
14JAN1
Drug
code
1235
1237
7315
7360
Schedule
I
I
I
I
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Page 3197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00648]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-768]
Bulk Manufacturer of Controlled Substances Application: Siemens
Healthcare Diagnostics Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Siemens Healthcare Diagnostics Inc. has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to Supplemental Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 15, 2021.
Such persons may also file a written request for a hearing on the
application on or before March 15, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on December 11, 2020, Siemens Healthcare Diagnostics
Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702-2461, applied
to be registered as a bulk manufacturer of the following basic class of
controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Ecgonine............................... 9180 II
------------------------------------------------------------------------
The company plans to produce the listed controlled substance in
bulk to be used in the manufacture of DEA exempt products. No other
activities for these drug codes are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-00648 Filed 1-13-21; 8:45 am]
BILLING CODE P
